NextCure, Inc.
Clinical-stage biopharma developing novel, first-in-class immunomedicines for cancer.
NXTC | US
Overview
Corporate Details
- ISIN(s):
- US65343E1082
- LEI:
- Country:
- United States of America
- Address:
- 9000 VIRGINIA MANOR ROAD, SUITE 200, 20705 BELTSVILLE
- Website:
- https://www.nextcure.com/
- Sector:
- Manufacturing
Description
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel, first-in-class immunomedicines for the treatment of cancer. The company's research is centered on identifying new immune targets and pathways to create therapies for patients who do not respond to or have relapsed after treatment with existing immunotherapies. NextCure's pipeline includes antibody-drug conjugates (ADCs) and other innovative immunotherapies designed to restore normal immune function and address significant unmet medical needs in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NextCure, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NextCure, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NextCure, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
